Institut Bergonié
Clinical trials sponsored by Institut Bergonié, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Blood test may spot breast cancer recurrence years earlier Results expected Oct 2026 (estimated)
- Can a Team-Based tech approach boost quality of life in older cancer patients? Results expected Oct 2026 (estimated)
- Scientists Fine-Tune radioactive drug dosing for prostate cancer Results expected Nov 2026 (estimated)
- AI takes on mysterious uterine tumors: a new hope for accurate diagnosis Results expected Dec 2026 (estimated)
- New combo therapy aims to knock down prostate cancer quickly Results expected Dec 2026 (estimated)
-
Can women with tiny breast tumors skip armpit surgery? study investigates.
Disease control Stopped earlyThis study looked at menopausal women over 50 with very small breast cancers (less than 10 mm). It compared standard surgery plus armpit lymph node removal versus surgery alone to see if skipping the extra procedure was safe. The goal was to reduce side effects like arm swelling …
Phase 3 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Study probes immune changes after heat ablation of lung tumors
Knowledge-focused Stopped earlyThis study looked at how radiofrequency ablation (RFA), a procedure that uses heat to destroy tumors, affects the immune system in people with lung metastases from colorectal cancer. Researchers measured immune cells in tumor samples and blood before and after RFA in 20 participa…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Lung cancer immunotherapy duration study halted early
Knowledge-focused Stopped earlyThis study looked at how long to continue immunotherapy in people with advanced non-small cell lung cancer who had already responded well to treatment for 6 to 12 months. The goal was to see if stopping or continuing treatment made a difference in keeping the cancer from growing.…
Phase 2 • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC